# Safety and Efficacy Study of Umbilical Mesenchymal Stem Cells for Liver Cirrhosis

> **NCT01573923** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Alliancells Bioscience Corporation Limited** · enrollment: 320 (estimated)

## Conditions studied

- Liver Cirrhosis

## Interventions

- **BIOLOGICAL:** mesenchymal stem cells
- **BIOLOGICAL:** Conventional therapy

## Key facts

- **NCT ID:** NCT01573923
- **Lead sponsor:** Alliancells Bioscience Corporation Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-07
- **Primary completion:** 2015-07
- **Final completion:** 2015-10
- **Target enrollment:** 320 (ESTIMATED)
- **Last updated:** 2015-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01573923

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01573923, "Safety and Efficacy Study of Umbilical Mesenchymal Stem Cells for Liver Cirrhosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01573923. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*